Difference between revisions of "Mixed germ cell tumour"
Jump to navigation
Jump to search
m (→IHC) |
(→IHC) |
||
| Line 66: | Line 66: | ||
A panel: | A panel: | ||
*PLAP. | *PLAP. | ||
*CD30 - [[embryonal carcinoma]]. | *CD30 +ve -- [[embryonal carcinoma]]. | ||
*CD117 - seminoma. | *CD117 +ve -- [[seminoma]]. | ||
*D2-40 - seminoma | *D2-40 +ve -- seminoma, useful for [[LVI]]. | ||
*Pankeratin - embryonal carcinoma. | *Pankeratin +ve -- embryonal carcinoma. | ||
*CEA-M. | *CEA-M. | ||
*EMA. | *EMA +ve -- metastatic carcinoma.<ref>{{Cite journal | last1 = Shek | first1 = TW. | last2 = Yuen | first2 = ST. | last3 = Luk | first3 = IS. | last4 = Wong | first4 = MP. | title = Germ cell tumour as a diagnostic pitfall of metastatic carcinoma. | journal = J Clin Pathol | volume = 49 | issue = 3 | pages = 223-5 | month = Mar | year = 1996 | doi = | PMID = 8675733 }}</ref> | ||
*Vimentin. | *Vimentin. | ||
*AFP - [[yolk sac tumour]]. | *AFP +ve -- [[yolk sac tumour]]. | ||
*A1A - yolk sac tumour. | *A1A +ve -- yolk sac tumour. | ||
==See also== | ==See also== | ||